A detailed history of Cullen/Frost Bankers, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 61 shares of ILMN stock, worth $8,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 26 134.62%
Holding current value
$8,793
Previous $2,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$105.28 - $135.9 $3,684 - $4,756
35 Added 134.62%
61 $7,000
Q2 2024

Aug 05, 2024

SELL
$101.05 - $133.57 $1,414 - $1,869
-14 Reduced 35.0%
26 $2,000
Q1 2024

May 10, 2024

SELL
$127.73 - $147.2 $25,546 - $29,439
-200 Reduced 83.33%
40 $5,000
Q4 2023

Feb 06, 2024

SELL
$92.79 - $142.53 $20,413 - $31,356
-220 Reduced 47.83%
240 $33,000
Q2 2023

Aug 04, 2023

SELL
$183.43 - $232.67 $12,656 - $16,054
-69 Reduced 13.04%
460 $86,000
Q1 2023

May 05, 2023

SELL
$193.75 - $232.55 $11,818 - $14,185
-61 Reduced 10.34%
529 $123,000
Q4 2022

Feb 13, 2023

SELL
$187.24 - $242.74 $16,289 - $21,118
-87 Reduced 12.85%
590 $119,000
Q3 2022

Nov 07, 2022

SELL
$177.23 - $227.44 $19,672 - $25,245
-111 Reduced 14.09%
677 $129,000
Q2 2022

Aug 05, 2022

SELL
$181.58 - $368.0 $32,321 - $65,504
-178 Reduced 18.43%
788 $145,000
Q1 2022

May 09, 2022

SELL
$303.87 - $423.8 $35,856 - $50,008
-118 Reduced 10.89%
966 $338,000
Q4 2021

Feb 07, 2022

SELL
$347.28 - $421.83 $28,129 - $34,168
-81 Reduced 6.95%
1,084 $412,000
Q3 2021

Nov 04, 2021

SELL
$405.61 - $524.84 $191,853 - $248,249
-473 Reduced 28.88%
1,165 $473,000
Q2 2021

Aug 05, 2021

SELL
$372.84 - $481.5 $174,116 - $224,860
-467 Reduced 22.19%
1,638 $775,000
Q1 2021

May 05, 2021

SELL
$361.28 - $504.76 $398,853 - $557,255
-1,104 Reduced 34.4%
2,105 $808,000
Q4 2020

Feb 08, 2021

SELL
$292.7 - $370.96 $258,454 - $327,557
-883 Reduced 21.58%
3,209 $1.19 Million
Q3 2020

Nov 05, 2020

SELL
$268.51 - $400.74 $133,180 - $198,767
-496 Reduced 10.81%
4,092 $1.27 Million
Q2 2020

Aug 05, 2020

SELL
$256.46 - $373.01 $11,797 - $17,158
-46 Reduced 0.99%
4,588 $1.7 Million
Q1 2020

May 01, 2020

SELL
$209.2 - $335.53 $21,129 - $33,888
-101 Reduced 2.13%
4,634 $1.27 Million
Q4 2019

Feb 06, 2020

SELL
$288.29 - $335.49 $62,270 - $72,465
-216 Reduced 4.36%
4,735 $1.57 Million
Q3 2019

Nov 01, 2019

SELL
$266.84 - $378.23 $80,585 - $114,225
-302 Reduced 5.75%
4,951 $1.51 Million
Q2 2019

Aug 01, 2019

SELL
$300.59 - $368.15 $75,748 - $92,773
-252 Reduced 4.58%
5,253 $1.93 Million
Q1 2019

Apr 30, 2019

SELL
$272.57 - $321.18 $69,232 - $81,579
-254 Reduced 4.41%
5,505 $1.71 Million
Q4 2018

Feb 06, 2019

SELL
$272.46 - $366.54 $1,907 - $2,565
-7 Reduced 0.12%
5,759 $1.73 Million
Q3 2018

Oct 29, 2018

SELL
$279.04 - $367.06 $80,642 - $106,080
-289 Reduced 4.77%
5,766 $2.12 Million
Q2 2018

Jul 27, 2018

SELL
$228.17 - $292.07 $83,510 - $106,897
-366 Reduced 5.7%
6,055 $1.69 Million
Q1 2018

May 11, 2018

SELL
$209.54 - $253.91 $41,488 - $50,274
-198 Reduced 2.99%
6,421 $1.52 Million
Q4 2017

Jan 31, 2018

SELL
$202.23 - $230.03 $83,318 - $94,772
-412 Reduced 5.86%
6,619 $1.45 Million
Q3 2017

Nov 02, 2017

BUY
$172.3 - $213.93 $1.21 Million - $1.5 Million
7,031
7,031 $1.4 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.